|
KMID : 0603820130190030173
|
|
Journal of Experimental & Biomedical Science
2013 Volume.19 No. 3 p.173 ~ p.179
|
|
|
Nucleotide?Binding Domain and Leucine?Rich Repeat Containing Receptor (NLR) and its Signaling Pathway
|
|
Park Sang-Wook
Gwon Sun-Yeong
Rhee Ki-Jong
|
|
|
Abstract
|
|
|
|
Since the identification and characterization of toll?like receptors (TLR) in Drosophila, numerous scientific studies have examined the role of TLRs in host innate immunity. Recent studies have suggested a convergence of the nuclear factor kappa B (NF?κB) signaling and cytokine production regulated by the cytosolic elicitor known as NLRs (nucleotide?binding domain and leucine?rich repeat containing domain receptors) as a key modulator in inflammatory diseases. Among the NLRs, NOD1 and NOD2 have been intensively investigated for its role in inflammatory bowel disease (IBD). On the other hand, NLRs such as NLRP3, NLRP1, and NLRC4 (also known as IPAF) have been identified to form the inflammasome to activate downstream signaling molecules in response to pathogenic microbes. There is evidence to suggest that substantial crosstalk exists for the TLR and NLR signaling pathway in response to pathogen associated molecular pattern (PAMP). However, the substrate and the mechanistic role of NLRs are largely unknown in innate immune response. Understanding the signaling mechanisms by which NLRs recognize PAMP and other danger signals will shed light on elucidating the pathogenesis of various human inflammatory diseases such as IBD.
|
|
|
KEYWORD
|
|
|
NLRs, NOD1, NOD2, TLR, IBD, inflammasome, PAMP
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|